evanhughes
New Member
- evanhughes   May 06, 2018 at 03:35: PM
evanhughes
New Member
Evan Hughes, NY Times Journalist, why haven’t you or any of your colleagues in media or print EXPOSED Purdue Pharmaceuticals as the original and longest-running drug kingpins in the opioid epidemic? Why has three plus decades past wherein this privately held multi billion dollar manufacturer of OxyContin that spent millions to market PAIN as a vital sign and millions more to persuade physicians to prescribe inordinate amounts of pills to patients bypassed as a company to headline The NY Times? If there are approximately 29,000 deaths reported in the recent year to opioid overdose- the egregiously highest percentage of which is OXYCODONE- then why, Evan Hughes, are you not investigating the longstanding relationships between Lobbyists and Purdue Executives, Manage Care Plans and Purdue Managed Markets, and Government Officials and Purdue Founders? INSYS Therapeutics is no doubt guilty for illegal marketing and kickbacks that have been exposed over the last several years, an obviously major crime since Medicare fraud involves the Government, but EXPONENTIALLY, the ubiquitous OxyContin, the pernicious growth of abuse fueled by PRIVATELY HELD PURDUE has debilitated the US society and economy more than any pharmaceutical company to date. Thousands are dead because of this extended release and that multipled into countless overseas generic imitations sold on the black market.
Why, Evan Hughes, are you looking for smoke in an old campfire when there’s an erupting volcano in the same valley?
Thank you and to all for serious replies.
Thanks for the post. I am still the author of the article and now I am posting from the username evanhughes. I realize this won't solve the verification problem (maybe I will figure that one out), but perhaps this will at least help with the imposter problem. Again, I can be reached at evanhughes@gmail.com and 917-538-3096.
About the Purdue Pharma story, you might be interested to know that NYT journalist Barry Meier's book Pain Killer, about OxyContin and Purdue and the origins of the opioid crisis, is soon to be reissued: https://www.amazon.com/Pain-Killer-Empire-Americas-Epidemic/dp/0525511105. I would also recommend a recent feature in The New Yorker magazine about the Sackler family and Purdue: https://www.newyorker.com/magazine/2017/10/30/the-family-that-built-an-empire-of-pain. The Los Angeles Times also did significant investigative work on the subject, as did (onetime LAT staffer) Sam Quinones in his book "Dreamland." Purdue has stayed out of court by settling cases before they reach trial, and as you point out, the company is privately held. These two factors pose significant barriers to journalists, and I think the work they have done in spite of those barriers is notable. The health news outlet STAT, owned by Boston Globe Media, recently went to court to petition a judge to lift the seal on documents that Purdue produced in pretrial discovery in a Kentucky case, before the case was settled. A judge ruled in favor of STAT, but Purdue appealed the ruling and no final ruling has been made.